InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
4,967.23
(
-0.88%
)
US TECH 100
16,578.00
(
-2.12%
)
Dow Jones
37,986.40
(
0.56%
)
Brent Oil
86.61
(
0.22%
)
Bitcoin
64,128.62
(
0.97%
)
Post# of 251538
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 826
Posts 119437
Boards Moderated 16
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 201850

Monday, 06/27/2016 4:15:18 PM

Monday, June 27, 2016 4:15:18 PM

Post# of 251538
RGLS—RG-101 on FDA clinical hold for SAEs:

http://finance.yahoo.com/news/regulus-reports-clinical-hold-rg-201000470.html

The FDA initiated the clinical hold after Regulus reported a second serious adverse event (SAE) of jaundice. The SAE occurred in a HCV patient with end-stage renal disease on dialysis enrolled in its on-going Phase I US study 117 days after receiving a single dose of RG-101.

The RG-101 HCV program was already on life support; time to pull the plug.

CC at 5pm ET.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up